Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGTA Technology for Postoperative Scars in Abdominal Donor Skin Area
ChiCTR2500112338Phase 4Recruiting
- Sponsor
- School and Hospital of Stomatology, China Medical University
- Start
- Nov 2025
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of regenerating agents in surgical scar (2 arms), sponsored by School and Hospital of Stomatology, China Medical University. Primary endpoints: Scar healing condition (Vancouver Scar Scale), Scar length, width and height and 2 more. Started Nov 2025; status: recruiting.
02
Drugs
regenerating agents
03
Conditions
surgical scar
Beyond the preview
Go deeper on ChiCTR2500112338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112338.